|$7,500,000||To provide general operating support.||2021 - 2024||DAF|
|$21,666,892||To support the Institute for Clinical and Economic Review research that provides independent analyses of the comparative cost effectiveness for newly-introduced pharmaceutical drugs.||2017 - 2021||LJAF|
|$5,232,002||To produce Institute for Clinical and Economic Review reports on new drugs that include information about a drug's comparative effectiveness, cost effectiveness, and potential budget impact.||2015 - 2017||LJAF|
Have an evidence-based week
Get The Abstract from Arnold Ventures delivered to your inbox.